Drug Profile


Alternative Names: Artecef; Arteether; Artether; Beta-arteether; Betamotil; SM 227; β-arteether

Latest Information Update: 30 Mar 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Shanghai Institute of Materia Medica
  • Developer Brocacef Holding
  • Class Antimalarials; Artemisinins; Small molecules
  • Mechanism of Action Free radical stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Falciparum malaria
  • Discontinued Toxoplasmosis

Most Recent Events

  • 30 Mar 2015 Launched for Falciparum malaria in India (IM) before March 2015
  • 30 Mar 2015 No recent reports on development identified - Registered for Falciparum malaria in France, Myanmar, Thailand, Niger, Nigeria, Sudan and Pakistan (IM)
  • 14 Aug 2002 A clinical study has been added to the pharmacokinetics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top